Moringa oleifera Lam. (Moringaceae): evaluación nutricional y clínica en modelos animales y correspondencia con investigaciones en humanos

Moringa oleifera es una especie vegetal que pertenece a la familia Moringaceae. Durante cientos de años, poblaciones de diferentes países han considerado que posee propiedades medicinales y nutritivas. Recientemente se le ha prestado atención en países tropicales y subtropicales de Europa del Este, América Latina, el Caribe y Asia, y se ha ganado un lugar en la industria de suplementos, ingredientes funcionales y en la fortificación de alimentos. El objetivo de este trabajo fue relacionar los hallazgos bioquímicos y fisiológicos determinados en modelos experimentales animales y los que se han logrado demostrar en humanos en los mismos aspectos, mediante el empleo de M. oleifera; con un llamado de atención a aquellas similitudes y diferencias entre el modelo animal y el prototipo humano. Los efectos beneficiosos de M. oleifera vinculados al tratamiento de la diabetes mellitus, dislipidemias y anemia se han asociado en gran medida al contenido y variedad de sustancias antioxidantes que posee y que complementan su valor en nutrientes. Esta revisión enfatiza en la necesidad de desarrollar experimentos controlados en humanos para estudiar el papel de los principios activos de M. oleifera en nutrición y clínica para establecer las formas idóneas de suministrar la planta y dosis óptimas que permitan lograr los efectos deseados, de manera que resulte aceptable al paladar y sea una solución sostenible en el tratamiento de estas enfermedades. Palabras clave: Moringa oleífera, modelos experimentales, antioxidantes, diabetes mellitus, dislipidemias, anemia

Anti-atherogenic properties associated with the antioxidant activity from the hydrophilic extracts of Halimeda incrassata (Chlorophyta, Bryopsidales)

Seaweeds are a source of natural antioxidants having potential application in oxidative stress and associated diseases. In this work, anti-atherogenic properties associated with the antioxidant activity from the hydrophilic extracts of Halimeda incrassata were studied. The phenolic content assessed inthe aqueous extract and fraction phenolic acids (FPA) was 0.13 ± 0.05 and 0.47 ± 0.09 mg of gallic acid equivalents (GAE)/g dry seaweed, respectively. In DPPH?, radical scavenging assay fractions exhibited a dependent concentration. The seaweeds extract inhibited the desoxirribose oxidation in the presenceor absence of EDTA (IC50 = 1.91± 0.09 mg/mL) (IC50 = 2.95 ± 0.01 mg/mL). In vivo antioxidant properties of FPA-H.incrassata were investigated in rats with a CCl4-induced liver injury. Pre-treatment with H.incrassata led to approximately 50% reductions in liver TBARS levels. The treatment with H. incrassataFPA also increased the activity of the CAT enzyme, which in turn resulted in an enhanced antioxidantdefense. The expression of Catalase by PCR-RT technique demonstrated a higher gene expression when compared with that which was observed in the CCl 4-treated group. Antiatherogenic properties were studied in the inhibition of lipoprotein oxidation mediated by Cu2+ or HRP/H2O2, free radicalscavenging, and metal ion chelation, and it was dose dependent with a higher concentration needed for the aqueous extract than for the FPA fraction. Antioxidant activity was also improved in macrophages as evaluated in the cell supernatant (by TBARS formation); and by luminol enhanced chemiluminescence after cell activation with zymosan; and a degree of cell lipoperoxidation wasdecreased by the Halimeda incrassata extract. The results of this work add to the antioxidant potential of the seaweed for its application in oxidative stress associated conditions.Fil: Vidal-Novoa, Alexis. Universidad de la Habana. Facultad de Biología; CubaFil: Costa-Mugica, Ariadna. Universidad de la Habana. Facultad de Biología; CubaFil: Zulueta Díaz, Yenisleidy de Las Mercedes. Universidad de la Habana. Facultad de Biología; Cuba. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Centro de Investigaciones en Química Biológica de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Centro de Investigaciones en Química Biológica de Córdoba; ArgentinaFil: Diaz-Gutierrez, Daylín. Universidad de la Habana. Facultad de Biología; CubaFil: de Oliveira e Silva, Ana, Mara. Universidade de Sao Paulo; BrasilFil: Vazquez, Ana María. Center For Molecular Inmunology; CubaFil: Claudina, Zaldívar-Munoz. Universidad de la Habana. Facultad de Biología; CubaFil: Dalva, Assuncao Portari de Mancini. Institute Butantan Sao Paulo; BrasilFil: Mancini-Filho, Jorge. Universidade de Sao Paulo; Brasi

Effect of aqueous rosemary extract (Rosmarinus officinalis L.) on the oxidative stress of diabetic rats

OBJETIVO: Avaliar o efeito do extrato aquoso de alecrim sobre o estresse oxidativo em ratos diabéticos. MÉTODOS: O extrato aquoso de alecrim foi obtido por método sequencial. Os fenólicos totais foram determinados pelo método de Folin Ciocateau e a atividade antioxidante in vitro foi determinada através de três métodos: β-caroteno/ácido linoleico, varredura do radical 2,2 Difenil-1-Picril-hidrazil e oxigen radical absorbance capacity. Ratos Wistar machos foram distribuídos em 5 grupos: controle, diabético, e três grupos de animais diabéticos tratados com extrato aquoso de alecrim em concentrações diferentes: 25, 50 ou 100mg/kg por via oral durante 30 dias. O diabetes foi induzido por estreptozotocina e, no final do experimento, foi coletado sangue para avaliar o percentual de hemoglobina glicada e os tecidos hepático e cerebral para determinação das enzimas antioxidantes: superóxido dismutase, catalase, glutationa peroxidase e glutationa redutase. RESULTADOS: Constatou-se que o extrato aquoso de alecrim apresentou altos teores de compostos fenólicos totais e expressiva atividade antioxidante in vitro nos três métodos de avaliação. O extrato aquoso de alecrim na concentração de 50mg/kg diminuiu o percentual de hemoglobina glicada e aumentou a atividade das enzimas catalase e glutationa peroxidase no fígado, e da superóxido dismutase no cérebro de ratos diabéticos. No entanto, não foi observado efeito dose-resposta nas demais concentrações analisadas. CONCLUSÃO: O extrato aquoso de alecrim apresenta significativa capacidade antioxidante in vitro, atribuída à presença de compostos fenólicos em sua composição. E, quando administrado em ratos na concentração de 50mg/kg, demonstrou-se eficiente na atenuação do estresse oxidativo presente no diabetes experimental.OBJECTIVE: This study assessed the effect of aqueous rosemary extract on the oxidative stress of diabetic rats. METHODS: Aqueous rosemary extract was obtained by the sequential method. Total phenolic content was determined by the Folin Ciocateau method and antioxidant activity in vitro was determined by the following methods: β-carotene/linoleic acid, 2,2 Difenil-1-Picril-hidrazil and oxygen radical absorbance capacity. Male Wistar rats were distributed into 5 groups: control, diabetic, and three groups of diabetic animals treated with aqueous rosemary extract in different concentrations: 25, 50 or 100mg/kg orally for 30 days. Diabetes was induced by streptozotocin and, at the end of the experiment, blood was collected to assess the percentage of glycated hemoglobin; liver and brain tissues were collected for the determination of the antioxidant enzymes: superoxide dismutase, catalase, glutatione peroxidase and glutatione reductase. RESULTS: Aqueous rosemary extract contains high levels of phenolic compounds and significant total antioxidant activity in vitro according to the three methods. Aqueous rosemary extract at a concentration of 50mg/kg decreased the percentage of glycated hemoglobin and increased the activity of glutatiose peroxidase and catalase enzymes in the liver and superoxide dismutase in the brain of diabetic rats. However, no dose-response effect was observed in the other concentrations. CONCLUSION: Aqueous rosemary extract presented significant antioxidant capacity in vitro attributed to its high phenolic compound content. When administered to rats at a concentration of 50mg/kg, it proved to be efficient against the oxidative stress secondary to experimental diabetes

Inhibition of LDL-oxidation and antioxidant properties related to polyphenol content of hydrophilic fractions from seaweed Halimeda Incrassata (Ellis) Lamouroux

LDL oxidation and oxidative stress are closely related to atherosclerosis. Therefore, natural antioxidants have been studied as promising candidates. In the present study, the LDL oxidation inhibition activity of bioactive compounds from Halimeda incrassata seaweed. associated to antioxidant capacity, was evaluated in vitro. Experimental work was conducted with lyophilized aqueous extract and phenolic-rich fractions of the seaweed and their effect on LDL oxidation was evaluated using heparin-precipitated LDL (hep-LDL) with exposure to Cu2+ ions and AAPH as the free radical generator. H. incrassata had a protective effect for hep-LDL in both systems and the presence of phenolic compounds contributed to the activity where phenolic-rich fractions showed significant capacity for inhibition of oxidation mediated by Cu2+ ions. The observed effect could be related to the antioxidant potential of polar fractions evidenced by reducing activity and DPPH center dot radical scavenging. The results obtained in vitro further support the antioxidant and LDL oxidation inhibition properties of H. incrassata and further knowledge toward future phytotherapeutic application of the seaweed.IFSIFS [F/4897-1]CIHR [MOP24447]CIHRCanadian Research Chair awardCanadian Research Chair awardGSEPGSEPCNPq (Brasil)CNPq- (Brasil

Multidifferential study of identified charged hadron distributions in ZZ-tagged jets in proton-proton collisions at s=\sqrt{s}=13 TeV

Jet fragmentation functions are measured for the first time in proton-proton collisions for charged pions, kaons, and protons within jets recoiling against a $Z$ boson. The charged-hadron distributions are studied longitudinally and transversely to the jet direction for jets with transverse momentum 20 $< p_{\textrm{T}} < 100$ GeV and in the pseudorapidity range $2.5 < \eta < 4$. The data sample was collected with the LHCb experiment at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 1.64 fb$^{-1}$. Triple differential distributions as a function of the hadron longitudinal momentum fraction, hadron transverse momentum, and jet transverse momentum are also measured for the first time. This helps constrain transverse-momentum-dependent fragmentation functions. Differences in the shapes and magnitudes of the measured distributions for the different hadron species provide insights into the hadronization process for jets predominantly initiated by light quarks.Comment: All figures and tables, along with machine-readable versions and any supplementary material and additional information, are available at https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-013.html (LHCb public pages

Study of the B−→Λc+Λˉc−K−B^{-} \to \Lambda_{c}^{+} \bar{\Lambda}_{c}^{-} K^{-} decay

The decay $B^{-} \to \Lambda_{c}^{+} \bar{\Lambda}_{c}^{-} K^{-}$ is studied in proton-proton collisions at a center-of-mass energy of $\sqrt{s}=13$ TeV using data corresponding to an integrated luminosity of 5 $\mathrm{fb}^{-1}$ collected by the LHCb experiment. In the $\Lambda_{c}^+ K^{-}$ system, the $\Xi_{c}(2930)^{0}$ state observed at the BaBar and Belle experiments is resolved into two narrower states, $\Xi_{c}(2923)^{0}$ and $\Xi_{c}(2939)^{0}$, whose masses and widths are measured to be $$m(\Xi_{c}(2923)^{0}) = 2924.5 \pm 0.4 \pm 1.1 \,\mathrm{MeV}, \\ m(\Xi_{c}(2939)^{0}) = 2938.5 \pm 0.9 \pm 2.3 \,\mathrm{MeV}, \\ \Gamma(\Xi_{c}(2923)^{0}) = \phantom{000}4.8 \pm 0.9 \pm 1.5 \,\mathrm{MeV},\\ \Gamma(\Xi_{c}(2939)^{0}) = \phantom{00}11.0 \pm 1.9 \pm 7.5 \,\mathrm{MeV},$$ where the first uncertainties are statistical and the second systematic. The results are consistent with a previous LHCb measurement using a prompt $\Lambda_{c}^{+} K^{-}$ sample. Evidence of a new $\Xi_{c}(2880)^{0}$ state is found with a local significance of $3.8\,\sigma$, whose mass and width are measured to be $2881.8 \pm 3.1 \pm 8.5\,\mathrm{MeV}$ and $12.4 \pm 5.3 \pm 5.8 \,\mathrm{MeV}$, respectively. In addition, evidence of a new decay mode $\Xi_{c}(2790)^{0} \to \Lambda_{c}^{+} K^{-}$ is found with a significance of $3.7\,\sigma$. The relative branching fraction of $B^{-} \to \Lambda_{c}^{+} \bar{\Lambda}_{c}^{-} K^{-}$ with respect to the $B^{-} \to D^{+} D^{-} K^{-}$ decay is measured to be $2.36 \pm 0.11 \pm 0.22 \pm 0.25$, where the first uncertainty is statistical, the second systematic and the third originates from the branching fractions of charm hadron decays.Comment: All figures and tables, along with any supplementary material and additional information, are available at https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-028.html (LHCb public pages

Measurement of the ratios of branching fractions R(D∗)\mathcal{R}(D^{*}) and R(D0)\mathcal{R}(D^{0})

The ratios of branching fractions $\mathcal{R}(D^{*})\equiv\mathcal{B}(\bar{B}\to D^{*}\tau^{-}\bar{\nu}_{\tau})/\mathcal{B}(\bar{B}\to D^{*}\mu^{-}\bar{\nu}_{\mu})$ and $\mathcal{R}(D^{0})\equiv\mathcal{B}(B^{-}\to D^{0}\tau^{-}\bar{\nu}_{\tau})/\mathcal{B}(B^{-}\to D^{0}\mu^{-}\bar{\nu}_{\mu})$ are measured, assuming isospin symmetry, using a sample of proton-proton collision data corresponding to 3.0 fb${ }^{-1}$ of integrated luminosity recorded by the LHCb experiment during 2011 and 2012. The tau lepton is identified in the decay mode $\tau^{-}\to\mu^{-}\nu_{\tau}\bar{\nu}_{\mu}$. The measured values are $\mathcal{R}(D^{*})=0.281\pm0.018\pm0.024$ and $\mathcal{R}(D^{0})=0.441\pm0.060\pm0.066$, where the first uncertainty is statistical and the second is systematic. The correlation between these measurements is $\rho=-0.43$. Results are consistent with the current average of these quantities and are at a combined 1.9 standard deviations from the predictions based on lepton flavor universality in the Standard Model.Comment: All figures and tables, along with any supplementary material and additional information, are available at https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-039.html (LHCb public pages

Antioxidant and neuroprotective activity of the extract from the seaweed, Halimeda incrassata (Ellis) Lamouroux, against in vitro and in vivo toxicity induced by methyl-mercury

A growing body of evidence suggests oxidative stress as part of the toxicity mechanism of methyl-mercury (MeHg) in cell cultures and animal models and so justifies the use of natural antioxidants as therapeutic alternatives. This research examines the effect of an aqueous extract from the marine seaweed Halimeda incrassata (Hi) against the oxidative stress induced by MeHg on in vitro and in vivo models. In GT1-7 mouse hypothalamic cell cultures, the extract of Hi increased cell viability and reduced ROS production after 24-h exposure to MeHgCl. Wistar rats, acutely intoxicated with MeHgCl, had reduced levels of serum and brain thiobarbituric reactive substances when treated with the Hi extract. Similarly, animals exposed to repeated doses of MeHgCl were protected by the seaweed extract from variations in body weight, food consumption and the appearance of neurological effects. This research supports the notion that oxidative stress is directly involved in MeHg intoxication, so that natural antioxidants, particularly those in the extract of Hi, can be useful therapeutic alternatives